Key Insights

Highlights

Treatment Research

9 treatments under study, led by Subprotocol F

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Enrolling By Invitation1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06699056Recruiting

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

NCT06763549Enrolling By Invitation

COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable

Showing all 2 trials

Research Network

Common Treatments

  • Subprotocol F1
  • Subprotocol B1
  • Subprotocol D1
  • 15minutes Of Sitting During Cor Ecg Acquistion1
  • Subprotocol A1

Active Sponsors

  • Peerbridge Health, Inc2

Top Investigators

Related Conditions

  • Hfref Heart Failure With Reduced Ejection Fraction2
  • Lvf2
  • Syncope2
  • Conduction Defect2
  • Hfpef Heart Failure With Preserved Ejection Fraction2

Activity Timeline